Enhancement of all-trans retinoic acid-induced differentiation by pH-sensitive nanoparticles for solid tumor cells

Macromolecular Bioscience

Volumn 14, Issue 3, 2014, Pages 369-379

  Wang, Yongjian ^a,b   Wang, Huizhen ^a   Lv, Xueming ^a   Liu, Congcong ^a   Qi, Linshuang ^a   Song, Xindi ^a   Yu, Ao ^a  

^a NANKAI UNIVERSITY   (China)

^b Collaborative Innovation Center of Chemical Science and Engineering   (China)

Author keywords

all trans retinoic acid; dendrimers; induced differentiation; intracellular delivery; nanoparticles

Indexed keywords

CELLS; CYTOLOGY; DENDRIMERS; DISEASES; NANOPARTICLES; PH; PHYSIOLOGY; TUMORS;

ACIDIC ENVIRONMENT; ALBUMIN SECRETION; ALL-TRANS RETINOIC ACIDS; ALL-TRANS-RETINOIC ACID; INTRACELLULAR DELIVERY; PHYSIOLOGICAL PH; POLYAMIDOAMINE DENDRIMERS; PROLIFERATION INHIBITION;

SYNTHESIS (CHEMICAL);

ALBUMIN; DENDRIMER; FLUORESCAMINE; NANOPARTICLE; POLYAMIDOAMINE; RETINOIC ACID; 3,4,5,6-TETRAHYDROPHTHALIC ACID ANHYDRIDE; DRUG CARRIER; PAMAM STARBURST; PHTHALIC ANHYDRIDE;

APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION ASSAY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYDROLYSIS; HYDROLYSIS KINETICS; IN VITRO STUDY; LIGHT SCATTERING; LIVER CELL CARCINOMA; MTT ASSAY; PH; PROTON NUCLEAR MAGNETIC RESONANCE; SOLID TUMOR; TRANSMISSION ELECTRON MICROSCOPY; TUMOR CELL; ZETA POTENTIAL; CHEMISTRY; DRUG EFFECTS; DRUG FORMULATION; LIVER CELL; METABOLISM; PATHOLOGY; SYNTHESIS; TUMOR CELL LINE;

CELL DIFFERENTIATION; CELL LINE, TUMOR; DENDRIMERS; DRUG CARRIERS; DRUG COMPOUNDING; HEPATOCYTES; HUMANS; HYDROGEN-ION CONCENTRATION; NANOPARTICLES; PHTHALIC ANHYDRIDES; TRETINOIN;

EID: 84896399908     PISSN: 16165187     EISSN: 16165195     Source Type: Journal    
DOI: 10.1002/mabi.201300295     Document Type: Article

References (41)

1. D. G. Tenen, Nat. Rev. Cancer 2003, 3, 89.
2. J. K. Rane, D. Pellacani, N. J. Maitland, Nat. Rev. Urol. 2012, 9, 595.
3. M. Leszczyniecka, T. Roberts, P. Dent, S. Grant, P. B. Fisher, Pharmacol. Therapeutics 2001, 90, 105.
4. A. I. Spira, M. A. Carducci, Curr. Opin. Pharmacol. 2003, 3, 338.
5. G. B. Pierce, W. C. Speers, Cancer Res. 1988, 48, 1996.
6. M. E. Huang, Y. C. Ye, S. R. Chen, J. R. Chai, J. X. Lu, L. Zhoa, L. J. Gu, Z. Y. Wang, Blood 1988, 72, 567.
7. F. D. Cruz, I. Matushansky, Oncotarget 2012, 3, 559.
8. E. Gocek, G. P. Studzinski, Crit. Rev. Clin. Lab. Sci. 2009, 46, 190.
9. H. Kawamata, M. Tachibana, T. Fujimori, Y. Imai, Curr. Pharm. Des. 2006, 12, 379.
10. L. Degos, Z. Y. Wang, Oncogene 2001, 20, 7140.
11. Z. Y. Wang, Z. Chen, Blood 2008, 111, 2505.
12. J. Abu, M. Batuwangala, K. Herbert, P. Symonds, Lancet Oncol. 2005, 6, 712.
13. D. Pasquali, V. Rossi, G. Bellastella, A. Bellastella, A. A. Sinisi, Curr. Pharm. Des. 2006, 12, 1923.
14. S. M. Coelho, M. Vaisman, D. P. Carvalho, Curr. Pharm. Des. 2005, 11, 2525.
15. A. Alisi, S. Leoni, A. Piacentani, L. Conti Devirgiliis, Liver Int. 2003, 23, 179.
16. L. J. Gudas, J. A. Wagner, J. Cell. Physiol. 2011, 226, 322.
17. D. L. Trump, D. C. Smith, D. Stiff, A. Adedoyin, R. Day, R. R. Bahnson, J. Hofacker, R. A. Branch, Cancer Chemother. Pharmacol. 1997, 39, 349.
18. J. S. Lee, R. A. Newman, S. M. Lippman, M. H. Huber, T. Minor, M. N. Raber, I. H. Krakoff, W. K. Hong, J. Clin. Oncol. 1993, 11, 959.
19. Y. Li, X. R. Qi, Y. Maitani, T. Nagai, Nanotechnology 2009, 20, 055106.
20. P. Opanasopit, T. Ngawhirunpat, T. Rojanarata, C. Choochottiros, S. Chirachanchai, Eur. J. Pharm. Sci. 2007, 30, 424.
21. M. Li, W. Song, Z. Tang, S. Lv, L. Lin, H. Sun, Q. Li, Y. Yang, H. Hong, X. Chen, ACS Appl. Mater. Interfaces 2013, 5, 1781.
22. Y. I. Jeong, K. D. Chung, H. Kim da, Y. H. Kim, Y. S. Lee, K. C. Choi, Int. J. Nanomed. 2013, 8, 485.
23. Y. Zhang, C. Xiao, M. Li, J. Chen, J. Ding, C. He, X. Zhuang, X. Chen, Macromol. Biosci. 2013, 13, 584.
24. I. J. Majoros, A. Myc, T. Thomas, C. B. Mehta, J. R. Baker, Biomacromolecules 2006, 7, 572.
25. N. Malik, R. Wiwattanapatapee, R. Klopsch, K. Lorenz, H. Frey, J. W. Weener, E. W. Meijer, W. Paulus, R. Duncan, J. Controlled Release 2000, 65, 133.
26. S. Sengupta, D. Eavarone, I. Capila, G. Zhao, N. Watson, T. Kiziltepe, R. Sasisekharan, Nature 2005, 436, 568.
27. Y. Wen, Z. Guo, Z. Du, R. Fang, H. Wu, X. Zeng, C. Wang, M. Feng, S. Pan, Biomaterials 2012, 33, 8111.
28. K. Zhang, Y. Wang, A. Yu, Y. Zhang, H. Tang, X. X. Zhu, Bioconjugate Chem. 2010, 21, 1596.
29. K. Zhang, A. Yu, D. Wang, W. Yang, J. Li, X. Zhang, Y. Wang, Mater. Lett. 2011, 65, 293.
30. C. F. Jones, R. A. Campbell, A. E. Brooks, S. Assemi, S. Tadjiki, G. Thiagarajan, C. Mulcock, A. S. Weyrich, B. D. Brooks, H. Ghandehari, D. W. Grainger, ACS Nano 2012, 6, 9900.
31. J. Shi, Z. Xiao, N. Kamaly, O. C. Farokhzad, Acc. Chem. Res. 2011, 44, 1123.
32. Y. Lee, S. Fukushima, Y. Bae, S. Hiki, T. Ishii, K. Kataoka, J. Am. Chem. Soc. 2007, 129, 5362.
33. Y. Lee, K. Miyata, M. Oba, T. Ishii, S. Fukushima, M. Han, H. Koyama, N. Nishiyama, K. Kataoka, Angew. Chem. Int. Ed. 2008, 47, 5163.
34. I. K. Oh, H. Mok, T. G. Park, Bioconjugate Chem. 2006, 17, 721.
35. M. Vandana, S. K. Sahoo, Biomaterials 2010, 31, 9340.
36. R. B. Kolhatkar, K. M. Kitchens, P. W. Swaan, H. Ghandehari, Bioconjugate Chem. 2007, 18, 2054.
37. C. L. Waite, S. M. Sparks, K. E. Uhrich, C. M. Roth, BMC Biotechnol. 2009, 9, 38.
38. M. Nakanishi, Y. Tomaru, H. Miura, Y. Hayashizaki, M. Suzuki, Nucleic Acids Res. 2008, 36, 3443.
39. F. Arce, O. Gatjens-Boniche, E. Vargas, B. Valverde, C. Diaz, Cancer Lett. 2005, 229, 271.
40. W. Wang, G. Xu, C. L. Ding, L. J. Zhao, P. Zhao, H. Ren, Z. T. Qi, FEBS J. 2013, 280, 1308.
41. A. Saovapakhiran, A. D'Emanuele, D. Attwood, J. Penny, Bioconjugate Chem. 2009, 20, 693.